On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...